Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease

OBJECTIVE: Inflammatory bowel disease (IBD) is a chronic, autoimmune, gastrointestinal disorder. Canada has one of the highest prevalence and incidence rates of IBD in the world. Diagnosis is challenging due to the similarity of symptoms to functional gastrointestinal disorders. Faecalcalprotectin (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Wong, Chiew Hsia, Chavannes, Mallory, Mohammadi, Tima, Rosenfeld, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500206/
https://www.ncbi.nlm.nih.gov/pubmed/30987989
http://dx.doi.org/10.1136/bmjopen-2018-027043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500206/
https://www.ncbi.nlm.nih.gov/pubmed/30987989
http://dx.doi.org/10.1136/bmjopen-2018-027043

Ejemplares similares